Celsion CorpAdd to My Watchlist

CLSN:USNASDAQ CMIndustry: Medical-Biomedical/Gene
  • 2.81
    Last
  • 0.08  -2.77%
    Today's Change
  • 2.89
    Previous Close
  • Today
     
    2.15
    4.03
    52 Week Low - High
8:10 pm ET 3/2/2015
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding20 million
Market Cap$56 million
Return on Equity ttm-81.08%
Last DividendCLSN:US does not pay a dividend
Earnings
EPS: Year Actual ttm-1.380
EPS: Year Est. 12/14 ttm-1.420
 
EPS: Quarterly Actual 9/14 -0.35
EPS: Quarterly Est. 12/14 -0.36
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate72.38
Company Description
Celsion Corporation is a development company specializing in heat based treatments for cancer and other diseases. The Company's products include a heat activated liposomal form of doxorubicin for the treatment for liver and breast cancers.
Revenue$500,000
Net Income$-8 million
Total Assets$46 million
Employees13
Web Sitewww.celsion.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!